Johnson & Johnson Completes Acquisition of Shockwave Medical
Shockwave is now part of Johnson & Johnson and will operate as a business unit within Johnson & Johnson MedTech.
- Shockwave is now part of Johnson & Johnson and will operate as a business unit within Johnson & Johnson MedTech.
- Joaquin Duato, Chairman and Chief Executive Officer of Johnson & Johnson, said, “Through Innovative Medicine and MedTech, Johnson & Johnson is transforming the trajectory of cardiovascular disease, one of the leading causes of death globally.
- We are delighted to welcome the Shockwave team to Johnson & Johnson and look forward to bringing their innovative IVL technology to more patients around the world.”
Tim Schmid, Executive Vice President and Worldwide Chairman of Johnson & Johnson MedTech, said, “Completing this acquisition is a significant milestone in the expansion of our leadership position in the medtech industry. - The transaction is expected to accelerate revenue growth for both Johnson & Johnson and Johnson & Johnson MedTech.